Tumour-infiltrating lymphocytes predict response to definitive chemoradiotherapy in head and neck cancer.
about
The promise of immunotherapy in head and neck squamous cell carcinomaAnti-Tumor Immunity in Head and Neck Cancer: Understanding the Evidence, How Tumors Escape and Immunotherapeutic ApproachesControl of CD8 T-Cell Infiltration into Tumors by Vasculature and MicroenvironmentTherapeutic Lymphoid Organogenesis in the Tumor MicroenvironmentThe Role of Lymphocytes in Radiotherapy-Induced Adverse Late Effects in the LungPrognostic significance of tumor infiltrating immune cells in oral squamous cell carcinomaMetabolomics of Therapy Response in Preclinical Glioblastoma: A Multi-Slice MRSI-Based Volumetric Analysis for Noninvasive Assessment of Temozolomide TreatmentHead and neck cancer relapse after chemoradiotherapy correlates with CD163+ macrophages in primary tumour and CD11b+ myeloid cells in recurrencesIncreased malignancy of oral squamous cell carcinomas (oscc) is associated with macrophage polarization in regional lymph nodes - an immunohistochemical studyFractal analysis of nuclear histology integrates tumor and stromal features into a single prognostic factor of the oral cancer microenvironment.Stromal infiltration of CD8 T cells is associated with improved clinical outcome in HPV-positive oropharyngeal squamous carcinoma.Association between Chemotherapy-Response Assays and Subsets of Tumor-Infiltrating Lymphocytes in Gastric Cancer: A Pilot Study.A phase I clinical trial utilizing autologous tumor-infiltrating lymphocytes in patients with primary hepatocellular carcinoma.Oropharyngeal squamous cell carcinomas differentially express granzyme inhibitors.Overcoming barriers to effective immunotherapy: MDSCs, TAMs, and Tregs as mediators of the immunosuppressive microenvironment in head and neck cancer.Prognostic Value of Tumor-Infiltrating Lymphocytes for Patients With Head and Neck Squamous Cell Carcinoma.The prognostic value of systemic and local inflammation in patients with laryngeal squamous cell carcinoma.Prognostic value, localization and correlation of PD-1/PD-L1, CD8 and FOXP3 with the desmoplastic stroma in pancreatic ductal adenocarcinoma.T cell abundance in blood predicts acute organ toxicity in chemoradiotherapy for head and neck cancer.Prognostic role and correlation of CA9, CD31, CD68 and CD20 with the desmoplastic stroma in pancreatic ductal adenocarcinoma.Prognostic impact of immune microenvironment in laryngeal and pharyngeal squamous cell carcinoma: Immune cell subtypes, immuno-suppressive pathways and clinicopathologic characteristics.Kill and spread the word: stimulation of antitumor immune responses in the context of radiotherapy.Locally Advanced Non-Small Cell Lung Cancer: Optimal Chemotherapeutic Agents and Duration.Tumor-infiltrating lymphocytes favor the response to chemoradiotherapy of head and neck cancer.Tumor-infiltrating lymphocytes for the treatment of metastatic cancer.Multiparametric immune profiling in HPV- oral squamous cell cancerThe PD-1/PD-L1 axis and human papilloma virus in patients with head and neck cancer after adjuvant chemoradiotherapy: A multicentre study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG).Induction chemotherapy for head and neck cancer: is there still a role?Human papilloma virus load and PD-1/PD-L1, CD8+ and FOXP3 in anal cancer patients treated with chemoradiotherapy: Rationale for immunotherapy.Spatial intratumoral heterogeneity of proliferation in immunohistochemical images of solid tumors.Telltale tumor infiltrating lymphocytes (TIL) in oral, head & neck cancer.Immunophenotyping of patients with oral squamous cell carcinoma in peripheral blood and associated tumor tissue.Phase I study with ONCOS-102 for the treatment of solid tumors - an evaluation of clinical response and exploratory analyses of immune markers.TILs in Head and Neck Cancer: Ready for Clinical Implementation and Why (Not)?New concepts of biomarkers and clinical outcomes for therapeutic cancer vaccines in clinical trials.Pretreatment lymphocyte-to-monocyte ratio as an independent prognostic factor for head and neck cancer.An adaptive immune response driven by mature, antigen-experienced T and B cells within the microenvironment of oral squamous cell carcinoma.Characterization of tumor-associated T-lymphocyte subsets and immune checkpoint molecules in head and neck squamous cell carcinoma.CD8+ tumour-infiltrating lymphocytes in relation to HPV status and clinical outcome in patients with head and neck cancer after postoperative chemoradiotherapy: A multicentre study of the German cancer consortium radiation oncology group (DKTK-ROG).Tumor-infiltrating CD8(+) T lymphocytes associated with clinical outcome in anal squamous cell carcinoma.
P2860
Q26744433-A34DAD61-031C-4B90-A19C-E64DAFBC28F4Q26774312-C7F6C839-29FD-4EE4-95ED-0DD401AB42B6Q26799117-B01C8267-EF2A-47AD-A5DC-6210B0033D42Q26799123-6567DFE3-6E6D-417F-A044-8D6BAA8C7A3CQ28070412-7A09AA6F-B0E9-421C-BF13-0CAA1128B8AEQ33733725-9DCB6A48-DED2-49F0-807C-5DDCFEBF6478Q33844943-5D960595-81B4-42DD-88FE-948F2AD8294BQ34354547-ADAAC470-412D-4EEE-93A7-0782E7E6F015Q34468743-CCB56C96-4363-4A7B-BEEA-F677B9DA5868Q35619757-97F32B12-6E65-4D22-9666-F54082A848E2Q36081369-790782C0-0165-4C57-B5B5-D57834ECB61AQ36490577-008F80AE-68A1-4BF5-AB22-3E2D40D5C7B1Q36562370-934B7740-BF19-4366-8FA0-2C0752F13FEDQ36823719-4E1FEBCF-100F-45EA-B369-F0753FB65513Q37017190-DF03F47B-7B7F-433A-ABEA-2BA4F8C3EDAEQ37439587-FCEF67B8-1C4C-4B34-A7DF-3A56E7551D66Q37441444-412BED3E-DA39-48D7-99B4-4803E77C0121Q37520133-C4C3B1AA-9637-41DD-9D8C-D1F5D1D8BC45Q37662334-EF2658C7-84C5-4397-942C-A6B40E852EB5Q37687298-68F5A668-67F3-4EFE-BBF5-0A3DAC25A33EQ37745995-31E345A3-F409-409F-9A10-9F7234B7F353Q38217593-C033374C-6635-4EBE-8806-16B5ACE3E34CQ38558894-5615432C-2540-45F9-BDCA-25FFE9AF0C36Q38627218-217B3EF1-229A-499D-92BC-1872A407B3BEQ38636573-C3C103E7-D656-44A1-A68D-53028397D248Q38671420-30D532DB-4A36-4D47-B3F1-FA0AFAEBD82DQ38686682-7AB6442C-2A6E-414A-95A9-70C2E589BE35Q38811999-286A64C0-E092-4B4C-8BC6-673594216BEDQ38839112-16C5DD24-0B44-4B63-94EB-24412D334AA4Q38856277-B5ED9191-E9BC-4085-AABA-0AB2C7E8A9A0Q38935248-33E2240D-5DBD-4419-B698-D9C0A4D57517Q38952717-CCDAD0B2-A151-476A-9B6E-571BF3257901Q39004582-521014B4-E4B6-44CF-9ED7-4A7E8209CDC9Q39055075-1BA04E38-2FD3-4C7F-8225-FF0E25AE1D6AQ39093698-DBA06056-72AD-46D3-B06C-9361CFE4CF9DQ39401725-57E3F2F2-7CE0-45B7-A894-F289A7EDF860Q40056727-F7E99676-0F93-41E8-B42A-78524BAFFE54Q40475503-9E1BEEE1-0A91-4BA6-AF16-EC8C018553C7Q40732246-77F1A733-61B3-4CD6-8740-EA74A7B1DE72Q41044428-44D8142E-2ECA-41FA-8966-A4E8DB8E2F0B
P2860
Tumour-infiltrating lymphocytes predict response to definitive chemoradiotherapy in head and neck cancer.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 15 October 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Tumour-infiltrating lymphocyte ...... erapy in head and neck cancer.
@en
Tumour-infiltrating lymphocyte ...... erapy in head and neck cancer.
@nl
type
label
Tumour-infiltrating lymphocyte ...... erapy in head and neck cancer.
@en
Tumour-infiltrating lymphocyte ...... erapy in head and neck cancer.
@nl
prefLabel
Tumour-infiltrating lymphocyte ...... erapy in head and neck cancer.
@en
Tumour-infiltrating lymphocyte ...... erapy in head and neck cancer.
@nl
P2093
P2860
P356
P1476
Tumour-infiltrating lymphocyte ...... herapy in head and neck cancer
@en
P2093
J Wagenblast
P2860
P2888
P304
P356
10.1038/BJC.2013.640
P407
P577
2013-10-15T00:00:00Z